[Diagnosing Alzheimer Dementia in People with Down Syndrome in Accordance with ICD, DSM V and A/T/N System].

Fortschritte der Neurologie · Psychiatrie Pub Date : 2022-09-01 Epub Date: 2022-03-23 DOI:10.1055/a-1771-6273
Georg Nübling, Olivia Wagemann, Sandra V Loosli, Elisabeth Wlasich, Adrian Danek, Johannes Levin
{"title":"[Diagnosing Alzheimer Dementia in People with Down Syndrome in Accordance with ICD, DSM V and A/T/N System].","authors":"Georg Nübling,&nbsp;Olivia Wagemann,&nbsp;Sandra V Loosli,&nbsp;Elisabeth Wlasich,&nbsp;Adrian Danek,&nbsp;Johannes Levin","doi":"10.1055/a-1771-6273","DOIUrl":null,"url":null,"abstract":"<p><p>Due to a triplication of the amyloid precursor protein (APP) gene on chromosome 21, most people with Down's Syndrome (DS) are at high risk of developing an Alzheimer type of dementia associated with Down's Syndrome (DS-AD). The diagnostic process of DS-AD is challenging due to the high variability of symptoms ranging from memory deficits to social withdrawal or aggression, as well as a broad spectrum of differential diagnoses. Currently, ICD-10, DSM-V and the novel A(amyloid)/T(tau)/N (neurodegeneration) system are available for classifying dementia, although DS-AD is not represented as a specific entity in any of these systems. Here, we discuss challenges in arriving at a diagnosis of Alzheimer dementia in people with DS in accordance with these diagnostic systems.</p>","PeriodicalId":509563,"journal":{"name":"Fortschritte der Neurologie · Psychiatrie","volume":" ","pages":"416-420"},"PeriodicalIF":0.0000,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Fortschritte der Neurologie · Psychiatrie","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1055/a-1771-6273","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/3/23 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2

Abstract

Due to a triplication of the amyloid precursor protein (APP) gene on chromosome 21, most people with Down's Syndrome (DS) are at high risk of developing an Alzheimer type of dementia associated with Down's Syndrome (DS-AD). The diagnostic process of DS-AD is challenging due to the high variability of symptoms ranging from memory deficits to social withdrawal or aggression, as well as a broad spectrum of differential diagnoses. Currently, ICD-10, DSM-V and the novel A(amyloid)/T(tau)/N (neurodegeneration) system are available for classifying dementia, although DS-AD is not represented as a specific entity in any of these systems. Here, we discuss challenges in arriving at a diagnosis of Alzheimer dementia in people with DS in accordance with these diagnostic systems.

[根据ICD、DSM V和A/T/N系统诊断唐氏综合征患者阿尔茨海默氏痴呆]。
由于21号染色体上淀粉样前体蛋白(APP)基因的三倍复制,大多数唐氏综合征(DS)患者发展为与唐氏综合征相关的阿尔茨海默型痴呆(DS- ad)的风险很高。DS-AD的诊断过程具有挑战性,因为从记忆缺陷到社交退缩或攻击等症状的高度可变性,以及广泛的鉴别诊断。目前,ICD-10、DSM-V和新的A(淀粉样蛋白)/T(tau)/N(神经变性)系统可用于对痴呆症进行分类,尽管DS-AD在任何这些系统中都没有作为特定实体表示。在这里,我们讨论的挑战到达诊断阿尔茨海默氏症的人与这些诊断系统相一致的退行性痴呆。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书